Tudor Investment Corp’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-9,388
Closed -$154K 3402
2025
Q2
$154K Sell
9,388
-2,952
-24% -$51K ﹤0.01% 3127
2025
Q1
$225K Buy
12,340
+8,655
+235% +$247K ﹤0.01% 2797
2024
Q4
$137K Sell
3,685
-10,127
-73% -$388K ﹤0.01% 2889
2024
Q3
$442K Sell
13,812
-3,240
-19% -$180K ﹤0.01% 2102
2024
Q2
$1.4M Buy
17,052
+4,874
+40% +$527K 0.01% 1280
2024
Q1
$1.76M Buy
12,178
+2,382
+24% +$201K 0.01% 1080
2023
Q4
$902K Buy
9,796
+375
+4% +$38.1K 0.01% 1503
2023
Q3
$1.55M Buy
+9,421
New +$1.22M 0.02% 1064
2022
Q2
Sell
-416
Closed -$229K 2135
2022
Q1
$229K Buy
+416
New +$251K 0.01% 1690
2021
Q1
Sell
-141
Closed -$201K 1577
2020
Q4
$201K Buy
+141
New +$150K 0.01% 1235
2020
Q3
Sell
-406
Closed -$284K 1313
2020
Q2
$284K Sell
406
-363
-47% -$210K 0.01% 902
2020
Q1
$269K Sell
769
-2,207
-74% -$1.56M 0.02% 715
2019
Q4
$1.87M Buy
2,976
+1,615
+119% +$790K 0.08% 308
2019
Q3
$456K Buy
+1,361
New +$436K 0.02% 737

Other funds holding CDLX

Tudor Investment Corp's CDLX Position: Q3 2025 in Review

Tudor Investment Corp sold out of Cardlytics (CDLX) in Q3 2025, closing a stake of 9,388 shares — an estimated $154K sold.

Tudor Investment Corp first reported a position in CDLX in Q3 2019 and held it in 14 quarters. The position peaked at $1.87M in Q4 2019. 81 funds tracked by Wall St. Rank hold CDLX as of Q3 2025.

  • Tudor Investment Corp reported no remaining Cardlytics position as of Q3 2025 after selling out during the quarter.
  • Tudor Investment Corp sold 9,388 Cardlytics shares in Q3 2025, an estimated $154K.
  • Tudor Investment Corp first reported a position in Cardlytics in Q3 2019 and held it in 14 quarters.
  • Tudor Investment Corp's Cardlytics position peaked at $1.87M in Q4 2019.
  • 81 funds tracked by Wall St. Rank held Cardlytics as of Q3 2025.

Based on Tudor Investment Corp's 13F filing for Q3 2025, filed 14 Nov 2025.